Inhibitors
- EBI-2511 [orb525775]
>98%
2098546-05-3
576.782
C34H48N4O4
O=C(C1=C2C=C(C3CCN(C(C)C)CC3)OC2=CC(N(CC)C4CCOCC4)=C1CC)NCC5=C(C)C=C(C)NC5=O
100 mg, 250 mg, 1 g - SSE15206 [orb525774]
>98%
1370046-40-4
371.45
C19H21N3O3S
S=C(N1N=C(C2=CC=CC=C2)CC1C3=CC(OC)=C(OC)C(OC)=C3)N
100 mg, 250 mg, 1 g - CK-869 [orb525773]
>98%
388592-44-7
394.28
C17H16BrNO3S
O=C1N(C2=CC=C(OC)C=C2OC)C(C3=CC=CC(Br)=C3)SC1
100 mg, 250 mg, 1 g - DMU2139(CYP1B1 inhibitor 6j) [orb525772]
>98%
1821143-80-9
289.33
C19H15NO2
O=C(C1=CC=C2C=C(OC)C=CC2=C1)/C=C/C3=CC=CN=C3
100 mg, 250 mg, 1 g - DMU-2105(CYP1B1 inhibitor 7k) [orb525771]
>98%
1031063-36-1
259.308
C18H13NO
C1=CN=CC(C(/C=C/C2=CC3C=CC=CC=3C=C2)=O)=C1
100 mg, 250 mg, 1 g - TRPM8 Antagonist [orb525770]
>98%
259674-19-6
398.5
C26H26N2O2
O=C([C@@H](N(CC1=CC=CC=C1)CC2=CC=CC=C2)CC3=CNC4=CC=CC=C43)OC
100 mg, 250 mg, 1 g - BGB-3111(Zanubrutinib) [orb525769]
>98%
1691249-45-2
471.55
C27H29N5O3
NC(C1=C2N(N=C1C3=CC=C(OC4=CC=CC=C4)C=C3)[C@H](C5CCN(C(C=C)=O)CC5)CCN2)=O
100 mg, 250 mg, 1 g - Belotecan hydrochloride(CKD-602) [orb525768]
>98%
213819-48-8
469.96
C25H28ClN3O4
O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=C(CCNC(C)C)C5=CC=CC=C5N=C4C3=C2)=O.[H]Cl
100 mg, 250 mg, 1 g - APD125(Nelotanserin) [orb525767]
>98%
839713-36-9
437.24
C18H15BrF2N4O2
COC1=C(C2=C(Br)C=NN2C)C=C(NC(NC3=C(F)C=C(F)C=C3)=O)C=C1
100 mg, 250 mg, 1 g - Rbin-1 [orb525766]
>98%
1351758-37-6
293.36
C16H23NO4
CC(C)(CO)[C@@H](O)C(NCCC(CC1=CC=CC=C1)=O)=O
100 mg, 250 mg, 1 g
